CYLD downregulation in human hepatocellular carcinoma cells antagonizes p53-mediated apoptosis

被引:0
|
作者
Kotantaki, P. [1 ]
Mosialos, G. [1 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Biol, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece
关键词
CYLD; Hepatocellular carcinoma; p53-mediated apoptosis;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TUE-061
引用
收藏
页码:450 / 451
页数:2
相关论文
共 50 条
  • [1] The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells
    Yuko Takeba
    Naoki Matsumoto
    Minoru Watanabe
    Sachiko Takenoshita-Nakaya
    Yuki Ohta
    Toshio Kumai
    Masayuki Takagi
    Satoshi Koizumi
    Takeshi Asakura
    Takehito Otsubo
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1545 - 1555
  • [2] The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells
    Takeba, Yuko
    Matsumoto, Naoki
    Watanabe, Minoru
    Takenoshita-Nakaya, Sachiko
    Ohta, Yuki
    Kumai, Toshio
    Takagi, Masayuki
    Koizumi, Satoshi
    Asakura, Takeshi
    Otsubo, Takehito
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1545 - 1555
  • [3] Identification and Analysis of P53-Mediated Competing Endogenous RNA Network in Human Hepatocellular Carcinoma
    Zhang, Yiming
    Kang, Ran
    Liu, Wenrong
    Yang, Yalan
    Ding, Ruofan
    Huang, Qingqing
    Meng, Junhua
    Xiong, Lili
    Guo, Zhiyun
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017, 13 (09): : 1213 - 1221
  • [4] Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway
    Zhu, Hanzhang
    Wang, Jingrui
    Yin, Junjie
    Lu, Bei
    Yang, Qijun
    Wan, Yafeng
    Jia, Changku
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 45 (03) : 1121 - 1135
  • [5] Proton Beam Induces P53-mediated Cell Cycle Arrest in HepG2 Hepatocellular Carcinoma Cells
    So-Young Chun
    Kyung-Soo Nam
    Kyu-Shik Lee
    Biotechnology and Bioprocess Engineering, 2020, 25 : 141 - 148
  • [6] Proton Beam Induces P53-mediated Cell Cycle Arrest in HepG2 Hepatocellular Carcinoma Cells
    Chun, So-Young
    Nam, Kyung-Soo
    Lee, Kyu-Shik
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2020, 25 (02) : 141 - 148
  • [7] Hepatitis B virus X protein inhibits p53-mediated upregulation of mitofusin-2 in hepatocellular carcinoma cells
    Wang, Weilin
    Zhou, Dongkai
    Wei, Jianfeng
    Wu, Zehui
    Cheng, Xiaofei
    Sun, Qiang
    Xie, Haiyang
    Zhou, Lin
    Zheng, Shusen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 421 (02) : 355 - 360
  • [8] CYLD downregulation is correlated with tumor development in patients with hepatocellular carcinoma
    Kinoshita, Hiroki
    Okabe, Hirohisa
    Beppu, Toru
    Chikamoto, Akira
    Hayashi, Hiromitsu
    Imai, Katsunori
    Mima, Kosuke
    Nakagawa, Shigeki
    Yokoyama, Naomi
    Ishiko, Takatoshi
    Shinriki, Satoru
    Jono, Hirofumi
    Ando, Yukio
    Baba, Hideo
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (02) : 309 - 314
  • [9] Apoptosis, PCNA and p53 in hepatocellular carcinoma
    Paiva, C
    Oshima, CTF
    Lanzoni, VP
    Forones, NM
    HEPATO-GASTROENTEROLOGY, 2002, 49 (46) : 1058 - 1061
  • [10] Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells
    Friedman, SL
    Shaulian, E
    Littlewood, T
    Resnitzky, D
    Oren, M
    ONCOGENE, 1997, 15 (01) : 63 - 70